Invesco, LLC Eli Lilly & CO Transaction History

Invesco, LLC

$235 Billion
Q1 2024

A detailed history of Invesco, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Invesco, LLC holds 5,423 shares of LLY stock, worth $4.98 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares

5,423

Previous 5,324 1.86%

Holding current value

$4.98 Million

Previous $3.1 Billion 35.94%

% of portfolio

1.79%

Previous 1.44%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $58,627 - $78,435	99 Added 1.86%	5,423 $4.22 Billion
Q4 2023 Jan 30, 2024	SELL	$525.19 - $619.13 $27,835 - $32,813	-53 Reduced 0.99%	5,324 $3.1 Billion
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $183,008 - $252,305	421 Added 8.49%	5,377 $2.89 Billion
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $1.74 Million - $2.32 Million	4,956 New	4,956 $2.32 Billion

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $872B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invesco, LLC with notifications on news.

Account